-
1دورية أكاديمية
المؤلفون: Francis Fagnani, Caroline Laurendeau, Marie deZelicourt, Jade Marshall
المصدر: Epilepsia Open, Vol 7, Iss 4, Pp 633-644 (2022)
مصطلحات موضوعية: healthcare cost, healthcare resource utilization, prevalence, refractory epilepsy, TSC, Neurology. Diseases of the nervous system, RC346-429
وصف الملف: electronic resource
Relation: https://doaj.org/toc/2470-9239
-
2دورية أكاديمية
المؤلفون: Frédéric Barbut, Tatiana Galperine, Philippe Vanhems, Alban Le Monnier, Bernard Durand-Gasselin, Frédérique Canis, Viviane Jeanbat, Anne Duburcq, Sarah Alami, Caroline Bensoussan, Francis Fagnani
المصدر: Health and Quality of Life Outcomes, Vol 17, Iss 1, Pp 1-7 (2019)
مصطلحات موضوعية: Clostridium difficile, Health-related quality of life, EQ-5D, France, Computer applications to medicine. Medical informatics, R858-859.7
وصف الملف: electronic resource
-
3دورية أكاديمية
المؤلفون: Bernard Combe, Rene-Marc Flipo, Alain Saraux, Francis Fagnani, Jacques Massol, Gabrielle Cukierman, Jean-Michel Joubert, Philippe Huot-Marchand
المصدر: RMD Open, Vol 6, Iss 1 (2020)
مصطلحات موضوعية: Medicine
وصف الملف: electronic resource
-
4
المؤلفون: John Ratcliffe, Lawrence Wallack, Francis Fagnani, Victor G. Rodwin
المصدر: The End of an Illusion ISBN: 9780520330504
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::07e1c32fc2b32fa8625dac74be1c0df1
https://doi.org/10.2307/jj.2430512.9 -
5
المؤلفون: Jean-Frédéric Blanc, Caroline Laurendeau, Marie de Zélicourt, Manel Dhaoui, Nadia Kelkouli, Francis Fagnani, Philippe Mathurin
المصدر: GastroHep.
مصطلحات موضوعية: Article Subject
وصف الملف: text/xhtml
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8be383de16c7562ea1123fd36d68fccc
-
6
المؤلفون: Brooke Harrow, Francis Fagnani, Camille Nevoret, Xuan-Mai Truong-Thanh, Marie de Zélicourt, Louis de Mestier
المصدر: Advances in Therapy. 39:1754-1771
مصطلحات موضوعية: Adult, Cohort Studies, Pancreatic Neoplasms, Neuroendocrine Tumors, Adolescent, Stomach Neoplasms, Intestinal Neoplasms, Humans, Pharmacology (medical), General Medicine, Somatostatin, Peptides, Cyclic, Retrospective Studies
-
7دورية أكاديمية
المؤلفون: Francis Fagnani, Jean-Paul Moatti, Christian Lefaure
المساهمون: Institut international d'administration publique
المصدر: Revue française d'administration publique 43(1):25-36
-
8دورية أكاديمية
المؤلفون: Thierry Schneider, Jacques Lochard, Francis Fagnani
المساهمون: Editions John Libbey Eurotext
المصدر: Sciences sociales et santé 5(3-4):157-178
-
9
المؤلفون: Alain Saraux, Bernard Combe, Francis Fagnani, Gabrielle Cukierman, Isabelle Bru, Jean-Michel Joubert, Jan-Christof Schuller, Jacques Massol, Rene-Marc Flipo
المساهمون: CHRU Brest - Service de Rhumatologie (CHU - BREST - Rhumato), Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Lymphocyte B et Auto-immunité (LBAI), Université de Brest (UBO)-Institut Brestois Santé Agro Matière (IBSAM), Université de Brest (UBO)-Institut National de la Santé et de la Recherche Médicale (INSERM), LabEX IGO Immunothérapie Grand Ouest, Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Institut de Génétique Moléculaire de Montpellier (IGMM), Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), Cemka-eval [Bourg La Reine], UCB Pharma, Colombes, UCB Pharma Brussels, Centre Hospitalier Régional Universitaire de Besançon (CHRU Besançon), Hôpital Roger Salengro [Lille]
المصدر: Clinical and experimental rheumatology
Clinical and experimental rheumatology, Clinical and Experimental Rheumatology Sas, 2021, 39 (4), pp.781-789مصطلحات موضوعية: MESH: Antirheumatic Agents, MESH: Arthritis, Rheumatoid, MESH: Humans, Immunology, MESH: Quality of Life, humanities, MESH: Prospective Studies, Arthritis, Rheumatoid, MESH: France, Treatment Outcome, Rheumatology, [SDV.MHEP.RSOA]Life Sciences [q-bio]/Human health and pathology/Rhumatology and musculoskeletal system, Antirheumatic Agents, Certolizumab Pegol, Quality of Life, Immunology and Allergy, Humans, Tumor Necrosis Factor Inhibitors, MESH: Tumor Necrosis Factor Inhibitors, France, Prospective Studies, MESH: Certolizumab Pegol, MESH: Treatment Outcome
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9f43619c59d8b8175ba814c2a7fc280
https://hal.umontpellier.fr/hal-03340763 -
10
المؤلفون: Francis Fagnani, Patrice Fardellone, Julie Gourmelen, Gaëlle Désaméricq, Florence Suzan, Corinne Emery
المصدر: Advances in Therapy. 36:969-975
مصطلحات موضوعية: Adult, medicine.medical_specialty, Database analysis, Population, Postmenopausal osteoporosis, Fractures, Bone, Internal medicine, medicine, Humans, Pharmacology (medical), education, Osteoporosis, Postmenopausal, Reimbursement, Aged, Retrospective Studies, Aged, 80 and over, education.field_of_study, Bone Density Conservation Agents, Diphosphonates, business.industry, Retrospective cohort study, General Medicine, Middle Aged, Inappropriate Prescriptions, Rheumatology, Denosumab, Female, France, business, medicine.drug